Akimoto Pharmaceuticals Private Limited

Akimoto Pharmaceuticals Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U24110MH2023PTC397186 Incorporated 09 January 2023 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma DPIIT Startup
Data last updated
Revenue · FY 2025
₹60.66 Lakh
Latest filing
Net profit · FY 2025
₹11.65 Lakh
Net margin 19.2%
EBITDA · FY 2025
₹16.02 Lakh
EBITDA margin 26.4%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings
Active GSTINs
2
GST registered

About Akimoto Pharmaceuticals Private Limited

Data last updated:

Akimoto Pharmaceuticals Private Limited is a private limited company based in Mumbai, Maharashtra, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 09 January 2023.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24110MH2023PTC397186. Its GSTIN is 27AAYCA2047A1ZR (Maharashtra). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Apurva Singh and Shivam Chaudhary.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 601 Anita Vihar Chs Ltd Akurli Rd Kandivali East Nr Lokhandwala Township, Mumbai, Maharashtra, India – 400101.

As per the financials filed for FY 2025, the company reported a revenue of ₹60.66 Lakh. For the same year it recorded a net profit of ₹11.65 Lakh (net margin 19.2%) and EBITDA of ₹16.02 Lakh (EBITDA margin 26.4%).

Company details

CIN U24110MH2023PTC397186
Registration Number 397186
Incorporation Date 09 January 2023
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Apurva Singh Director Shivam Chaudhary Director

Recognitions & Rankings of Akimoto Pharmaceuticals

DPIIT recognised startup Government of India
Startup India

Contact details

Akimoto Pharmaceuticals Private Limited's registered office is in Mumbai, Maharashtra.

  • Registered Address
    C – 601 Anita Vihar Chs Ltd Akurli Rd Kandivali East Nr Lokhandwala Township, Mumbai, Maharashtra, India – 400101
  • Industry
    Pharma, Drug Formulation & Development
Comprehensive company report
Akimoto Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Akimoto Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GWholesale and retail trade; repair of motor vehicles and motorcycles46Wholesale trade, except of motor vehicles and motorcycles

To see the full business activity and turnover split of Akimoto Pharmaceuticals Private Limited, buy the company report.

Financials of Akimoto Pharmaceuticals Private Limited

FY 2025 filings available

Akimoto Pharmaceuticals Private Limited reported revenue of ₹60.66 Lakh for FY 2025.

Revenue · FY 2025
₹60.66 Lakh
Net profit · FY 2025
₹11.65 Lakh margin 19.2%
EBITDA · FY 2025
₹16.02 Lakh margin 26.4%

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹16.02 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹11.65 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin26.4%
Net Profit Margin19.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Akimoto Pharmaceuticals Private Limited, buy the company report.

Board of directors of Akimoto Pharmaceuticals Private Limited

Akimoto Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Apurva Singh
Also directs: Quantz Healthcare and Research Private Limited
Director09 Jan 20233 Years 9 MonthsCurrent
Shivam ChaudharyDirector09 Jan 20233 Years 9 MonthsCurrent
View all directors

MSME payment delays

No delayed payments to MSME suppliers are on our record for Akimoto Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Akimoto Pharmaceuticals has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
27AAYCA2047A1ZRMaharashtraActive16 Feb 2023
09AAYCA2047A1ZPUttar PradeshActive10 May 2023

To see the full GST registrations and return filing status of Akimoto Pharmaceuticals Private Limited, buy the company report.

Recent activity

Akimoto Pharmaceuticals Private Limited has 5 board changes on record since 2023: 2 appointments and 3 cessations. The latest: Narvesh Kumar ceased to be Director on 08 Jul 2024.

AGM
Akimoto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Akimoto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Ceased
Narvesh Kumar ceased to be Director.
Ceased
Harsh Vardhan Atreya ceased to be Director.
Ceased
Vijay Parshuram Raturi ceased to be Director.
Appointed
Apurva Singh was appointed as Director.
Appointed
Shivam Chaudhary was appointed as Director.
Incorporation
09 Jan 2023
Akimoto Pharmaceuticals Private Limited was registered on 09 Jan 2023 with Roc Mumbai & aged 3 years 9 months as per MCA records.

Frequently asked questions

Akimoto Pharmaceuticals is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 09 January 2023 (3+ years old) and is registered under CIN U24110MH2023PTC397186.

Akimoto Pharmaceuticals has 2 current directors:

The latest financial statements of Akimoto Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Akimoto Pharmaceuticals is 27AAYCA2047A1ZR, registered in Maharashtra. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 09AAYCA2047A1ZP (Uttar Pradesh).

The CIN (Corporate Identification Number) of Akimoto Pharmaceuticals is U24110MH2023PTC397186. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Akimoto Pharmaceuticals was incorporated on 09 January 2023, making it 3+ years old. It is registered with the Registrar of Companies, Mumbai.

Narvesh Kumar ceased to be Director on 08 Jul 2024. Harsh Vardhan Atreya ceased to be Director on 09 Dec 2023. Vijay Parshuram Raturi ceased to be Director on 09 Dec 2023. Akimoto Pharmaceuticals has 5 board changes on record in total.

Yes, Akimoto Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Akimoto Pharmaceuticals is at C – 601 Anita Vihar Chs Ltd Akurli Rd Kandivali East Nr Lokhandwala Township, Mumbai, Maharashtra, India – 400101.

Akimoto Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.